haleon plc glp-1 receptor agonist medications Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Emerging Frontiers in GLP-1 Therapeutics:
Description
J., Vilsboll, T

10.1016/S0140-6736(18)32261-X

This paradox may reflect a treatment landscape that appears complex and confusing, making it difficult for practitioners to identify the right drug for the right patient

doi: 10.3389/FPHAR.2022.825417 73 HlscherC

Raz I, Wilson PW, Strojek K, et al